Staging classifications for hepatocellular carcinoma

Expert Review of Molecular Diagnostics

Volumn 5, Issue 3, 2005, Pages 377-383

  Van Deusen, Mathew A ^a   Abdalla, Eddie K ^b   Vauthey, Jean Nicolas ^b   Roh, Mark S ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Classification schemes; Hepatocellular carcinoma; Revised AJCC UICC staging classification; Staging

Indexed keywords

CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER RESECTION; PATIENT SELECTION; PREDICTION; PROGNOSIS; REVIEW;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER; LYMPHATIC METASTASIS; NEOPLASM STAGING;

EID: 18844394783     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.5.3.377     Document Type: Review

References (20)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin. Liver Dis. 19, 271-285 (1999).
2. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 47, 4967-4972 (1987).
3. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 350, 1142-1143 (1997).
4. Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 351, 214-215 (1998).
5. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340(10), 745-750 (1999).
6. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60, 646-649 (1973).
7. Okuda K, Ohtsuki T, Obata H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56, 918-928 (1985). First system to include tumor-related factors and assessment of liver function.
8. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28, 751-755 (1998). Increased discriminatory ability of Cancer of the Liver Italian Program compared with Tumor Node Metastasis (TNM) and Okuda staging.
9. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31, 840-845 (2000).
10. Ueno S, Tanabe G, Sako K et al. Discrimination value of the new western prognostic system (CLIP Score) for hepatocellular carcinoma in 662 Japanese patients. Hepatology 34, 529-534 (2001).
11. Farinati F, Rinaldi M, Gianni S, Naccarato R. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 89, 2266-2273 (2000).
12. Levy I, Sherman M. The Liver Cancer Study Group of the University of Toronto. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 50, 881-885 (2002).
13. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 19, 329-338 (1999). Barcelona Clinic Liver Cancer provides treatment algorithm based on anticipated survival.
14. Izumi R, Shimizu K, Ii T et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106, 720-727 (1994).
15. Chiappa A, Zbar AP, Podda M et al. Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection. Hepatogastroenterology 48, 229-234 (2001).
16. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 88, 538-543 (2000).
17. Poon RT, Fan S. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg. Oncol. Clin. N. Am. 12, 35-50 (2003). Validated the accuracy of the revised American Joint Committee on Cancer (AJCCyinternational Union Against Cancer (UICC) in predicting survival differences in patients with early stages of disease (Stage I vs. II, Stage II vs. IIA).
18. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J. Gastroenterol. 38, 207-215 (2003). Japan Integrated Staging score incorporates TNM stage by the Liver Cancer Study Group of Japan and Child-Pugh classification.
19. Manual for Staging Cancer, fifth edition. Beahrs OH, Hensen DE, Hutter RW et al. (Eds), JB Lippincott, PA, USA (1997).
20. Vauthey JN, Lauwers GY, Esnaola NF et al. Simplified staging for hepatocellular carcinoma. J. Clin. Oncol. 20, 1527-1536 (2002). Revised AJCC/UICC identifies major vascular invasion, microvascular invasion and the presence of severe fibrosis/cirrhosis as independent predictors of death.